PTH and hypercalcemia disease: A retrospective analysis of advanced thyroid cancer patients also showed that MTKIs reduce calcium levels through both PTH-dependent and PTH-independent mechanisms, suggesting their efficacy in correcting hypercalcemia in PC (28).